Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
latest_posts
- 1
Involved Vehicles for Seniors: Track down the Best Picks for Solace and Dependability - 2US FDA approves Kura-Kyowa's blood cancer therapy
- 3Signature Scents: A Manual for Outstanding Fragrances
- 4Ukrainian Army Converts E38 BMW 7-Series Into Multiple Rocket Launch Platform
- 5At 72, Kathie Lee Gifford says aging isn’t what she expected. 'The golden years? It’s a lie.’
- We may have less control over how long we live than previously thought
- 4 injured in suburban Philadelphia nursing home explosion file negligence lawsuit
- What loving-kindness meditation is and how to practice it in the new year
- Top notch Remote Earphones for Audiophiles
- Kaiser Permanente affiliates to pay $556 million to resolve US claims alleging Medicare fraud
- These HGTV stars made a pledge to keep their kids off smartphones. Here's how it's going.
- Ergonomic Office Seats for Work spaces
- 1st human missions to Mars should hunt for signs of life, report says
- Vote in favor of Your #1 BWM Vehicles
